Two previously unreported prognostic associations in CRC, namely the TP53 mutation and the total mutation burden, confirmed correlations with the KRAS homolog and B-Raf proto-oncogenes (BRAF) were identified through multigene panels. The gene discussed is TP53; the disease is colorectal carcinoma.